Back to Basics Understanding FDA Labeling Requirements

Welcome back! Today we’re doing a quick refresher and going back to basics on one of the most critical components in our industry: product labeling. The Food and Drug Administration (FDA) mandates specific labeling requirements to ensure that medical devices, drug therapies, and human cells, tissues, and cellular and tissue-based products (HCT/Ps) are properly communicated to users. Clear, accurate labeling helps protect patients, guide healthcare professionals, and supports manufacturers in meeting legal and regulatory requirements.

The FDA labeling rules can vary depending on the type of healthcare product. Medical devices include instruments and apparatus used in diagnosis or treatment. Drug therapies encompass medications intended to treat, cure, or prevent diseases. HCT/Ps refer to products derived from human cells or tissues, such as skin grafts, used for transplantation or therapy. Each category falls under a distinct regulatory framework influencing their labeling requirements, which is why it’s important to know what you’re working with before you decide what must go on a label.

HCT/Ps

HCT/P labeling uses unique identification numbers and must identify the product’s source, processing methods, and intended use while maintaining traceability from the donor to the end-user. The FDA requires labels to display information about donor screening and testing, storage conditions, and expiration dating. HCT/P labels should also include warnings regarding potential risks and instructions for safe handling. Additional information is required to ensure traceability and minimize risk of disease transmission.

• Distinct Identification Code: Every HCT/P must be labeled with a unique alphanumeric identifier that relates the product to the donor and all related records.

• Donor Eligibility Notification: The container must include a statement summarizing the donor eligibility determination (e.g., whether the donor was screened and tested and found negative for communicable diseases).

• Description of Product: The label must clearly identify the product and tissue source material(s).

• Warnings/Biohazards: Labels must include warning statements, such as “Warning: Advise patient of communicable disease risks” or “For autologous use only”, when applicable.

• Manufacturer Information: Name and address of the manufacturer (or the responsible person/establishment) must be included.

• Storage Conditions: Specific storage temperatures or requirements must be noted.

• Expiration Date: If applicable, the expiration date must be on the label.

Medical Devices

Medical device labeling must provide clear instructions, warnings, and information about the device’s intended use. The FDA requires labels to include the manufacturer's name and address, unique device identifier (UDI), and usage directions. Labels should also highlight contraindications, precautions, and any relevant safety information. UDI labeling is now standard for most devices which aids in tracking and post-market surveillance.

• Product Name & Manufacturer: Clearly stated name of the device and the name/address of the manufacturer, packer, or distributor.

• Intended Use: Detailed, clear description of what the device does and who should use it.

• Unique Device Identifier (UDI): A mandatory alphanumeric code (per 21 CFR 830) identifying the device’s device identifier (DI) and production identifier (PI) components.

• Instructions for Use (IFU): Directions for safe handling, operation, maintenance, and disposal.

• Warnings and Precautions: Specific, highlighted, and easy-to-read warnings about potential hazards.

• Traceability: Unique lot or serial numbers are required to facilitate recalls.

• Sterility/Single-Use: If applicable, the label must state the method of sterilization and if the device is for single use only.

• Labeling Components:

  • Immediate Container Label: The tag on the actual device package.

  • Outside Package Label: Information on the external wrapper or retail box.

  • Supporting Documentation: Brochures, inserts, and manuals.

Drug Therapies

Drug labeling is highly regulated and must include comprehensive information such as the drug’s name, dosage, administration route, and approved indications. Manufacturers must provide warnings, contraindications, side effects, and detailed instructions for use. Additionally, the FDA requires labeling to include lot numbers, expiration dates, and storage conditions. Patient package inserts and medication guides are often mandated for specific drugs to enhance patient understanding.

• General Requirements

  • Statement of Identity: The drug’s name and its pharmacologic category.

  • Net Quantity: The total amount of drug (e.g., number of tablets, volume).

  • Manufacturer Information: Name and address of the manufacturer, packer, or distributor.

  • Lot/Batch Number: Used to identify the manufacturing history.

  • Expiration Date: Mandatory for ensuring potency over the established shelf life.

  • Storage Instructions: Proper storage conditions (e.g., temperature).

• Prescription Drug Labeling: Prescription labeling is more complex, primarily designed for healthcare professionals

  • Highlights Section: A concise summary of prescribing information.

  • Full Prescribing Information: Boxed warnings, contraindications, adverse reactions, and drug interactions.

  • Patient Labeling: FDA-approved materials like Medication Guides or Patient Package Inserts.

  • Dosage/Administration: Specific instructions on how to use the drug.

• Physical Label Characteristics

  • Legibility: Labels must be clear and easily read.

  • Permanence: Labels must adhere properly to the container throughout its intended shelf life.

  • Controlled Substances: For controlled substances, the schedule symbol (e.g., C-II) must be prominently displayed.

• Special Considerations

  • Tamper-Evident Packaging: Required for most OTC products, with a description of the feature on the label.

  • Pregnancy/Breast-feeding Warning: Mandatory on many OTC products.

  • Electronic Labeling: While the FDA-approved labeling must be provided in physical format, URLs or QR codes are acceptable additions.

While all three (3) industry areas require clear identification, usage instructions, and safety warnings, drug therapies often demand more detailed clinical information and patient focused materials. Medical device labeling emphasizes operational instructions and device tracking, whereas HCT/Ps focus on traceability, donor information, and minimize and preventing disease transmission. The depth of labeling requirements reflects the unique risks and regulatory priorities associated with each industry.

Key Considerations for Manufacturers

• Ensure labels including claims and marketing materials meet FDA standards for clarity, accuracy, and completeness.

• Regularly review regulatory updates to stay compliant with evolving requirements.

• Implement quality control measures to verify label consistency across batches.

• Train staff on labeling regulations and documentation procedures.

• Leverage tools for label management and traceability.

Manufacturers must prioritize accurate and compliant labeling to meet FDA standards and safeguard patients. By understanding the distinct requirements for medical devices, drug therapies, and HCT/Ps, manufacturers can tailor their labeling strategies for each product and meeting regulatory obligations. Thanks for stopping by, see you next time!

Have a question? Contact us here!

[1] https://www.ecfr.gov/current/title-21/chapter-I/subchapter-L/part-1271

[2] https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211

[3] https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-801